Peter is a Senior Principal and Head of MedTech Solutions at IQVIA China.

Peter has near 14+ years’ experiences of business consulting and 8+ years’ policy insight in healthcare. Prior to IQVIA, Peter was head of Medtech and sector growth officer of Ipsos in China since 2011 and senior consultant for industrial fields and B2B market in Nomura Research Institute.
Practice focuses on MedTech, pharmaceuticals, smart hospital and research institutions.

Anita Wei is the Vice President of Government Affairs for Danaher China and a member of
Danaher China Leadership Team (CLT). She reports to Global VP/Group President of Danaher
China.

Anita is taking the lead in developing and maintaining central and local government relations,
managing cooperation programs with government, enhancing Danaher corporate branding in
China. She also responsible for policy monitoring and analysis, evidence-based value access as
well as industry alliance for policy shaping. She and her team are currently mainly responsible for
supporting all Operation Companies (OpCos) across four platforms within Danaher.

Anita serves as the Chair of AmCham Shanghai Healthcare Committee and Executive Committee
Delegate of AdvaMed China. She is actively involved in industry-related affairs.

Prior to joining Danaher, Anita was the Vice President Public Affairs and Communications for BD
Greater China. Prior to that, she also worked for Novartis Pharma as Head of Communications for
Greater China. Anita is also an advocate of diversity and inclusion and has been very active in
promoting women's development. She is the co-founder for Carnation Project of China
Development and Research Foundation (CDRF), advocating for women health and well-being.

Anita holds a Bachelor's degree in Economics from University of International Business and
Economics and a Master's degree in international Business from the University of Sydney.